Modeling Approaches for Estimating Breast Cancer Probability Using Conventional Risk Factors and Continuous Assessment of Mammographic Parenchymal Density
##article.numberofdownloads## 0
##article.numberofviews## 2
pdf (Русский)

Keywords

breast cancer
risk
binary logistic regression
linear discriminant analysis
hierarchical cluster analysis
decision trees

How to Cite

Pasynkov, D. V., Mikhaltsova, M. A., Petrov, E. A., Busygina, O. V., Romanycheva, E. A., & Merinov, S. N. (2026). Modeling Approaches for Estimating Breast Cancer Probability Using Conventional Risk Factors and Continuous Assessment of Mammographic Parenchymal Density. Voprosy Onkologii, 72(4), 2605. https://doi.org/10.37469/0507-3758-2026-72-4-2605

Abstract

Introduction. Currently available breast cancer (BC) risk models demonstrate limited prognostic value.

Aim. To develop multiparametric BC probability models incorporating both conventional risk factors and a quantitative measure of mammographic density, and to assess their accuracy.

Materials and Methods. The study included 82 women with histologically confirmed BC and 269 women without BC. In all participants, conventional BC risk factors were recorded, and mammographic parenchymal density along with its mean annual change was assessed. Classification models were developed using binary logistic regression, linear discriminant analysis, hierarchical cluster analysis, and decision tree analysis.

Results. Correlation analysis revealed weak correlations between BC risk factors and the presence of disease (r² = 0.060–0.367) in most cases. The only exception was a moderate correlation (r² = 0.609) between a history of breast biopsy and BC probability. When mammographic density change was not accounted for, the binary logistic regression model yielded the best performance: for the entire sample, sensitivity was 67.50 % and specificity was 94.42 %. For patients with ACR A–B breast density, these values were 75.86 % and 92.42 %, respectively; for patients with ACR C–D density, 80.56 % and 89.26 %, respectively. When mammographic density change was incorporated, the sensitivity and specificity of the binary logistic regression model increased to 81.82 % and 97.62 %, respectively, for the entire sample, and reached 100.00 % and 100.00 % for both ACR A–B and ACR C–D subgroups.

Conclusion. Combining mammographic density and its mean annual change with conventional BC risk factors within a binary logistic regression model provides high predictive accuracy (88.40–100.00 %).

https://doi.org/10.37469/0507-3758-2026-72-4-2605
##article.numberofdownloads## 0
##article.numberofviews## 2
pdf (Русский)

References

Coles C.E., Earl H., Anderson B.O., et al. The Lancet Breast Cancer Commission. Lancet. 2024; 403(10439): 1895-1950.-DOI: https://doi.org/10.1016/S0140-6736(24)00747-5.

Shi J., Li J., Gao Y., et al. The screening value of mammography for breast cancer: an overview of 28 systematic reviews with evidence mapping. J Cancer Res Clin Oncol. 2025; 151: 102.-DOI: https://doi.org/10.1007/s00432-025-06122-z.

Canelo-Aybar C., Ferreira D.S., Ballesteros M., et al. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer. J Med Screen. 2021; 28(4): 389-404.-DOI: https://doi.org/10.1177/0969141321993866.

de Munck L., Siesling S., Fracheboud J., et al. Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in The Netherlands. Br J Cancer. 2020; 123(7): 1191-1197.-DOI: https://doi.org/10.1038/s41416-020-0968-6.

Bodewes F.T.H., vanAsselt A.A., Dorrius M.D., et al. Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis. Breast. 2022; 66: 62-68.-DOI: https://doi.org/10.1016/j.breast.2022.09.007.

Bener A., Barışık C.C., Acar A., et al. Assessment of the gail model in estimating the risk of breast cancer: effect of cancer worry and risk in healthy women. Asian Pac J Cancer Prev. 2019; 20 (6): 1765-1771.-DOI: https://doi.org/ 10.31557/APJCP.2019.20.6.1765.

Zhang L., Jie Z., Xu S., et al. Use of receiver operating characteristic (ROC) curve analysis for Tyrer-Cuzick and gail in breast cancer screening in Jiangxi Province, China. Med Sci Monit. 2018; 24: 5528-5532.-DOI: https://doi.org/10.12659/MSM.910108.

Fitzpatrick D., Pirie K., Reeves G., et al. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis. PLoSMed. 2023; 20 (3): e1004188.-DOI: https://doi.org/10.1371/journal.pmed.1004188.

Пасынков Д.В., Михальцова М.А., Фатыхов Р.И., et al. Прогнозирование риска рака молочной железы на основе непрерывной количественной оценки ее маммографической плотности. Поволжский онкологический вестник. 2025; 16 (1): 36-47. [Pasynkov D.V., Mikhaltsova М.А., Fatykhov R.I., et al. The prediction of breast carcinoma risk based on the continuous quantitative mammographic breast density parameter. Oncology Bulletin of Volga Region. 2025; 16 (1): 36-47 (In Rus)].

Thakur P., Seam R.K., Gupta M.K., et al. Breast cancer risk factor evaluation in a Western Himalayan state: A case–control study and comparison with the Western World. South Asian J Cancer. 2017; 6(3): 106-109.-DOI: https://doi.org/10.4103/sajc.sajc_157_16.

Tang D.-D., Ye Z.-J., Liu W.-W., et al. Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data. The Breast. 2025; 79: 103862.-DOI: https://doi.org/10.1016/j.breast.2024.103862.

Obeagu E.I., Obeagu G.U. Breast cancer: A review of risk factors and diagnosis. Medicine (Baltimore). 2024; 103(3): e36905.-DOI: https://doi.org/10.1097/MD.0000000000036905.

Cobain E.F., Milliron K.J., Merajver S.D. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. SeminOncol. 2016; 43(5): 528-535.-DOI: https://doi.org/10.1053/j.seminoncol.2016.10.001.

Wan A., Zhang G., Ma D., et al. An overview of the research progress of BRCA gene mutations in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023; 1878(4): 188907.-DOI: https://doi.org/10.1016/j.bbcan.2023.188907.

Han Y., Moore J.X., Colditz G.A., et al. Family history of breast cancer and mammographic breast density in premenopausal women. JAMA Netw Open. 2022; 5(2): e2148983.-DOI: https://doi.org/10.1001/jamanetworkopen.2021.48983.

Łukasiewicz S., Czeczelewski M., Forma A., et al. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 2021; 13(17): 4287.-DOI: https://doi.org/10.3390/cancers13174287.

Poorolajal J., Heidarimoghis F., Karami M., et al. Factors for the primary prevention of breast cancer: A meta-analysis of prospective cohort studies. J Res Health Sci. 2021; 20; 21(3): e00520.-DOI: https://doi.org/10.34172/jrhs.2021.57.

Zhang S., Guclu S.B., Lipsyc-Sharf M., Kapoor N.S. Pregnancy and breast cancer in young women: current updates and future directions. Ther Adv Med Oncol. 2025;17.-DOI: https://doi.org/10.1177/17588359251369973.

Aurin J., Thorlacius H., Butt S.T. Age at first childbirth and breast cancer survival: a prospective cohort study. BMC Res Notes. 2020; 13(1): 9.-DOI: https://doi.org/10.1186/s13104-019-4864-1.

Xiong F., Wang J., Nierenberg J.L., et al. Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. Br J Cancer. 2023; 129(4): 648-655.-DOI: https://doi.org/10.1038/s41416-023-02345-4.

Xiong F., Wang J., Nierenberg J.L., et al. Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. Br J Cancer. 2023; 129(4): 648-655.-DOI: https://doi.org/10.1038/s41416-023-02345-4.

Burke A., O’Driscoll J., Abubakar M., et al. A systematic review of determinants of breast cancer risk among women with benign breast disease. npj Breast Cancer. 2025; 11(16).-URL: https://www.nature.com/articles/s41523-024-00703-w.

Клюшкин И.В., Пасынков Д.В., Бусыгина О.В., et al. К вопросу о возможном повышении риска рака молочной железы у пациенток, перенесших оперативные вмешательства на ней по поводу доброкачественных процессов. Казанский медицинский журнал. 2015; 96, 3: 316-321.-DOI: https://doi.org/10.17750/KMJ2015-316. [Klyushkin I.V., Pasynkov D.V., Busygina O.V., et al. On the possibility of an increased risk of breast cancer in patients who underwent breast surgeries for benign diseases. Kazan Medical Journal. 2015; 96, 3: 316-321.-DOI: https://doi.org/10.17750/KMJ2015-316 (In Rus)]

Madorsky Feldman D., Sklair-Levy M., Laitman Y., et al. Breast biopsies and breast cancer risk in Israeli BRCA germline pathogenic variant carriers. Breast Cancer Res Treat. 2025; 213: 377-384.-DOI: https://doi.org/10.1007/s10549-025-07787-3.

Goodman M.T., Cologne J.B., Moriwaki H., et al. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med. 1997; 26: 144-53.-DOI: https://doi.org/10.1006/pmed.1996.9979.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2026